UPL Limited (UPL)

Name: UPL Limited (UPL) — historial de estados financieros
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.

Basic Materials · Wall Street (EE. UU.) · Última actualización: 2026-09-20

UPL Limited, together with its subsidiaries, manufactures and sells pesticides, insecticides, and micronutrients in India, Brazil, the United States, the United Kingdom, and internationally. It operates through Crop protection, Seeds & Post-Harvest solutions, and Non-Agro segments.

Cifras clave

Capitalización bursátil: ₹490 billion
Ingresos (ejercicio cerrado en 2026-03-31): ₹513.0B
Beneficio neto: ₹19.2B
Margen bruto: 48.9%
Margen neto: 3.7%

Ver gráficos interactivos y estados completos →

Cuenta de resultados anual

Cuenta de resultados	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Ingresos totales	₹513.0B	₹462.6B	₹426.0B	₹531.3B
Beneficio bruto	₹250.9B	₹217.4B	₹178.3B	₹255.1B
Ingresos operativos (EBIT)	₹71.0B	₹56.2B	₹28.5B	₹87.5B
Ingresos netos	₹19.2B	₹9.0B	(₹12.0B)	₹35.7B

Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.

Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de UPL. /companies/us/UPL

Empresas similares

La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.

English version →Todas las acciones

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.